Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

FULC
Fulcrum Therapeutics, Inc. Common Stock
stock NASDAQ

At Close
Mar 9, 2026 3:59:56 PM EDT
7.93USD-2.938%(-0.24)1,034,359
0.00Bid   0.00Ask   0.00Spread
Pre-market
Mar 9, 2026 9:27:30 AM EDT
7.61USD-6.854%(-0.56)80,204
After-hours
Mar 9, 2026 4:00:30 PM EDT
7.94USD+0.126%(+0.01)1,078
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsMore
open chart   
open chart   
Market Cap
510.82M
Industry
Biotechnology
Next Earnings
May 18, 2026 (69d)
FULC Stats
Avg. Vol. 10 Day
1,680,481
Avg. Vol. 30 Day
941,352
Employees
89
Market Cap
510,823,603
Shares Out.
66,600,209
On/Off Exchange
56%/44%
6 Month Beta
0.48
1 Year Beta
1.06
2 Year Beta
1.23
3 Year Beta
1.34
52 Week Low
2.32
52 Week High
15.74
SMA50
10.26
SMA200
8.74
1 Week
-1.79%
1 Month
-25.02%
3 Month
-47.47%
6 Month
+5.94%
1 Year
+158.25%
2 Year
-30.78%
5 Year
-36.35%
Profile
what if we could regulate genes, not just discover them? what if we could treat disease at their genetic source? what if we could integrate multiple disciplines to develop breakthrough medicines? what if you could be a part of a passionate team committed to the patients we serve? we can. we will. we are. join us. we are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. a fulcrum is defined as the point on which a lever rests, balances and pivots. fulcrum therapeutics is intervening in gene regulatory mechanisms to unlock the information contained in the human genome. the fulcrum product engine is dedicated to bringing balance to the genetic on and off switches in disease. our approach the sequencing of the human genome has provided incredible insight into disease biology, yet the richness of biology comes from the dynamic on and off switches that control the genome – gene regulation. the fulcrum product eng

FULC Stock Summary

Fulcrum Therapeutics, Inc. Common Stock (NASDAQ:FULC) stock price today is $7.93, and today's volume is 1,034,359. FULC is down -2.938% today. The 30 day average volume is 941,352. FULC market cap is 510.82M with 66,600,209 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC